Clinical Trials List
2024-08-01 - 2028-01-31
Phase III
Not yet recruiting3
ICD-10C43.9
Malignant melanoma of skin, unspecified
ICD-10D03.9
Melanoma in situ, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9172.9
Malignant melanoma of skin, site unspecified
-
Trial Applicant
ICON Clinical Research Pte Ltd
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 劉奕廷 無
- Tak-Wah Wong 無
- 顏志傑 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
720 participants
